Language

CAS NO:89-24-7 5-Phenylimidazolidine-2,4-dione

CAS NO:89-24-7 5-Phenylimidazolidine-2,4-dione

CAS NO:89-24-7 NAME:5-Phenylimidazolidine-2,4-dione MF：C9H8N2O2 MW：176.17 EINECS：201-890-5 APPEARANCE:Off-White to Pale Yellow solid COA:Provide Sample:Negotable

Categories：

Life Science Chemicals

Pharmaceutical Intermediates

Email：sale06@alfachem.cn

Inquiry

Chat Now

Product introduction

PRODUCT NAME	5-Phenylhydantoin
CAS NO	89-24-7
MP	182°C
Solubility	DMSO, Methanol
DENSITY	1.276±0.06 g/cm3(Predicted)
STORAGE	2-8°C
DELIVERY	2-3DAYS
PACKAGE	According client's request

Synonyms
phenylhydantoin, 5-Phenylhydantoin, Hydantoin, 5-phenyl-,
2,4-Imidazolidinedione, 5-phenyl-, Hydantoin, 5-phenyl- (8CI),
5-phenylimidazolidine-2,4-dione;

Description of 5-Phenylhydantoin CAS NO:89-24-75-Phenylhydantoin CAS NO:89-24-7 is a low-energy molecule that binds to the 5-ht7 receptor, which is a subtype of serotonin receptor. It has been shown to have an inhibitory effect on locomotor activity in mice and can be used to treat diabetic neuropathy.

5-Phenylhydantoin CAS NO:89-24-7 also interacts with sodium citrate, which is a molecule that regulates the pH of animal cells. The liquid chromatography method was used to determine the concentration of 5-phenylhydantoin in human liver tissue. This drug is active against human macrophages and can induce tumor necrosis factor alpha (TNF-α) secretion from these cells. A monoclonal antibody was used to detect the presence of 5-phenylhydantoin in biological samples such as urine or serum.

Applications of 5-Phenylhydantoin CAS NO:89-24-7

1. Preclinical Investigations in Drug Delivery Systems
5-Phenylhydantoin, a major metabolite of the antiseizure drug phenytoin, plays a significant role in preclinical investigations, particularly in drug delivery to the brain.

2. Metabolism Studies

3. Biochemical Pharmacology

4. Electrochemical Studies
Electrochemical characterization of phenytoin and its derivatives, including 5-phenylhydantoin, offers insights into their behavior and interactions at the molecular level.

5. Investigating Stereoselective Metabolism

Future Directions
There are ongoing studies on the derivatives of 5-Phenylhydantoin for their potential as anticonvulsant agents . There are also studies on novel serotonin 5-HT2A receptor antagonists derived from 5-Phenylhydantoin for use as potential antiplatelet agents

Key words: